Q3 2023 Holdings
Filed 2023-11-14 | 70 holdings | $304.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $21.9M | 300,000 | 7.2% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $18.8M | 330,000 | 6.2% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $18.2M | 150,000 | 6.0% |
| Moonlake Immunotherapeutics(MLTX)Put | CLASS A ORD | 61559X104 | $14.3M | 250,000 | 4.7% |
| Akero Therapeutics Inc(AKRO)Call | COM | 00973Y108 | $12.6M | 250,000 | 4.2% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $9.3M | 80,000 | 3.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $8.4M | 57,500 | 2.8% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $8.4M | 1,000,000 | 2.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $8.0M | 85,000 | 2.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $7.7M | 110,000 | 2.5% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $7.6M | 664,132 | 2.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.1M | 140,000 | 2.3% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $7.1M | 400,000 | 2.3% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $7.0M | 185,000 | 2.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $6.7M | 400,000 | 2.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $6.3M | 650,000 | 2.1% |
| Rocket Pharmaceuticals Inc(RCKT)Call | COM | 77313F106 | $6.0M | 295,000 | 2.0% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $6.0M | 525,000 | 2.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $5.8M | 115,000 | 1.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $5.0M | 130,000 | 1.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $4.8M | 40,000 | 1.6% |
| Syndax Pharmaceuticals Inc(SNDX)Put | COM | 87164F105 | $4.4M | 300,000 | 1.4% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $4.3M | 705,881 | 1.4% |
| Replimune Group Inc(REPL)Call | COM | 76029N106 | $4.3M | 250,000 | 1.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $4.2M | 275,000 | 1.4% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $4.2M | 1,325,000 | 1.4% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $4.1M | 325,000 | 1.4% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $4.1M | 395,000 | 1.3% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $4.0M | 350,000 | 1.3% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $3.9M | 215,000 | 1.3% |
| Cymabay Therapeutics Inc(CBAYUSD)Call | COM | 23257D103 | $3.5M | 237,900 | 1.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.4M | 98,951 | 1.1% |
| Immunovant Inc(IMVT)Put | COM | 45258J102 | $3.3M | 85,000 | 1.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $3.0M | 101,443 | 1.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.9M | 200,000 | 1.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $2.8M | 175,000 | 0.9% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $2.8M | 55,000 | 0.9% |
| Aerovate Therapeutics Inc | COM | 008064107 | $2.7M | 201,197 | 0.9% |
| Morphosys AG | SPONSORED ADS | 617760202 | $2.7M | 400,000 | 0.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.7M | 90,000 | 0.9% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $2.6M | 60,000 | 0.9% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $2.6M | 325,000 | 0.9% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.5M | 225,000 | 0.8% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $2.2M | 300,000 | 0.7% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $2.1M | 175,000 | 0.7% |
| Karuna Therapeutics Inc | COM | 48576A100 | $2.1M | 12,500 | 0.7% |
| Acelyrin Inc | COM | 00445A100 | $2.0M | 200,000 | 0.7% |
| Acelyrin IncPut | COM | 00445A100 | $2.0M | 200,000 | 0.7% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $2.0M | 100,000 | 0.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.0M | 75,000 | 0.7% |